{
  "meta": {
    "data_length": 1,
    "message": "Statement id stmt:ema:lumykras:0:0 retrieved successfully",
    "request_url": "https://api.moalmanac.org/statements?statement_id=stmt%3Aema%3Alumykras%3A0%3A0",
    "status": "success",
    "status_code": 200,
    "timestamp_elapsed": 0.002231,
    "timestamp_received": "2026-10-16T23:00:25.274149+00:00Z",
    "timestamp_returned": "2026-10-16T23:00:25.276380+00:00Z",
    "trace_id": "3af27e44-5336-4355-870c-eacd308ab66d"
  },
  "service": {
    "github": "https://github.com/vanallenlab/moalmanac-db",
    "name": "Molecular Oncology Almanac",
    "license": "GPL-2.0",
    "release": "draft",
    "url": "https://moalmanac.org",
    "last_updated": "2026-08-02"
  },
  "data": [
    {
      "id": "stmt:ema:lumykras:0:0",
      "type": "Statement",
      "description": "The European Medicines Agency (EMA) has authorized sotorasib as a monotherapy for the treatment of adult patients with advanced non-small cell lung cancer (NSCLC) with the KRAS p.G12C variant and who have progressed after at least one prior line of systemic therapy.",
      "contributions": [
        {
          "id": "ctrb:vanallenlab:2024-10-20:0",
          "type": "Contribution",
          "description": "Adding EMA approvals for use to database",
          "date": "2024-10-20",
          "contributor": {
            "id": "agent:user:vanallenlab",
            "type": "Agent",
            "agentType": "contributor",
            "name": "Van Allen lab",
            "description": "Van Allen lab, Dana-Farber Cancer Institute"
          }
        },
        {
          "id": "ctrb:ema:2022-01-06:0",
          "type": "Contribution",
          "description": "Indication received approval from the European Commission.",
          "date": "2022-01-06",
          "contributor": {
            "id": "agent:org:ema",
            "type": "Agent",
            "agentType": "organization",
            "name": "European Medicines Agency",
            "description": "Regulatory agency that approves medicines for use in the European Union."
          }
        }
      ],
      "reportedIn": [
        {
          "id": "doc:ema:lumykras",
          "type": "Document",
          "documentType": "Regulatory approval",
          "name": "Lumykras (sotorasib) [product information]. EMA.",
          "title": null,
          "aliases": [],
          "description": "Amgen Europe BV. Lumykras (sotorasib) [product information]. European Medicines Agency website. https://www.ema.europa.eu/en/documents/product-information/lumykras-epar-product-information_en.pdf. Revised February 2024. Accessed March 19, 2024.",
          "urls": [
            "https://www.ema.europa.eu/en/documents/product-information/lumykras-epar-product-information_en.pdf",
            "https://www.ema.europa.eu/en/medicines/human/EPAR/lumykras"
          ],
          "doi": null,
          "pmid": null,
          "extensions": [
            {
              "name": "agent",
              "value": {
                "id": "agent:org:ema",
                "type": "Agent",
                "agentType": "organization",
                "name": "European Medicines Agency",
                "description": "Regulatory agency that approves medicines for use in the European Union."
              },
              "description": "The organization that published this document."
            },
            {
              "name": "company",
              "value": "Amgen Europe BV.",
              "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
            },
            {
              "name": "drug_name_brand",
              "value": "Lumykras",
              "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
            },
            {
              "name": "drug_name_generic",
              "value": "sotorasib",
              "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
            },
            {
              "name": "first_publication_date",
              "value": "2022-03-31",
              "description": "The publication date for the initial version of this document."
            },
            {
              "name": "identification_number",
              "value": null,
              "description": "Identification number used by the publishing organization."
            },
            {
              "name": "publication_date",
              "value": "2024-02-27",
              "description": "The publication date for the document."
            },
            {
              "name": "status",
              "value": "Active",
              "description": "Whether this document is Active or Deprecated within moalmanac-db."
            }
          ]
        }
      ],
      "direction": "supports",
      "proposition": {
        "id": "prop:vtxr:411",
        "type": "VariantTherapeuticResponseProposition",
        "predicate": "predictsSensitivityTo",
        "subjectVariant": {
          "type": "CategoricalVariant",
          "description": "Placeholder. Cat-VRS does not yet support sets of categorical variants. See the 'biomarkers' extension for biomarkers associated with this Proposition."
        },
        "conditionQualifier": {
          "id": "dis:ncit:C2926",
          "conceptType": "Disease",
          "name": "Non-Small Cell Lung Cancer",
          "mappings": [
            {
              "relation": "exactMatch",
              "coding": {
                "id": "coding:oncotree:NSCLC",
                "code": "NSCLC",
                "name": "Non-Small Cell Lung Cancer",
                "system": "https://oncotree.mskcc.org",
                "systemVersion": "oncotree_2025_10_03",
                "iris": [
                  "https://oncotree.mskcc.org/?version=oncotree_2025_10_03&field=NAME&search=Non-Small+Cell+Lung+Cancer+%28NSCLC%29"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "solid_tumor",
              "value": true,
              "description": "Boolean value for if this tumor type is categorized as a solid tumor."
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C2926",
            "code": "C2926",
            "name": "Lung Non-Small Cell Carcinoma",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C2926"
            ]
          }
        },
        "objectTherapeutic": {
          "id": "tx:ncit:C154287",
          "conceptType": "Therapy",
          "name": "Sotorasib",
          "mappings": [
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:rxcui:2550714",
                "code": "2550714",
                "name": "sotorasib",
                "system": "RxNorm",
                "systemVersion": "02-Mar-2026",
                "iris": [
                  "https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=2550714"
                ]
              }
            },
            {
              "relation": "relatedMatch",
              "coding": {
                "id": "coding:omop:1536963",
                "code": "1536963",
                "name": "sotorasib",
                "system": "OMOP",
                "systemVersion": "v20260227",
                "iris": [
                  "https://athena.ohdsi.org/search-terms/terms/1536963"
                ]
              }
            }
          ],
          "extensions": [
            {
              "name": "therapy_strategy",
              "value": [
                "RAS inhibition"
              ],
              "description": "Associated therapeutic strategy or mechanism of action of the therapy."
            },
            {
              "name": "therapy_type",
              "value": "Targeted therapy",
              "description": "Type of cancer treatment from cancer.gov: https://www.cancer.gov/about-cancer/treatment/types"
            }
          ],
          "primaryCoding": {
            "id": "coding:ncit:C154287",
            "code": "C154287",
            "name": "Sotorasib",
            "system": "https://evsexplore.semantics.cancer.gov",
            "systemVersion": "26.08e",
            "iris": [
              "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C154287"
            ]
          }
        },
        "extensions": [
          {
            "name": "biomarkers",
            "value": [
              {
                "id": "bmkr.criterion:45",
                "present": true,
                "subject": {
                  "id": "bmkr:45",
                  "type": "CategoricalVariant",
                  "name": "KRAS p.G12C",
                  "constraints": [
                    {
                      "type": "DefiningAlleleConstraint",
                      "allele": {
                        "id": "ga4gh:VA.udBCHwlrf8xNiRy_19bLi-h5LhnZLgCt",
                        "type": "Allele",
                        "name": "NP_004976.2:p.Gly12Cys",
                        "aliases": [
                          "NP_004976.2:p.G12C",
                          "KRAS p.G12C"
                        ],
                        "description": "VRS variation of NP_004976.2:p.Gly12Cys",
                        "digest": "udBCHwlrf8xNiRy_19bLi-h5LhnZLgCt",
                        "expressions": [
                          {
                            "syntax": "hgvs.p",
                            "value": "NP_004976.2:p.Gly12Cys",
                            "extensions": [
                              {
                                "name": "hgvs.p_short",
                                "value": "p.G12C"
                              }
                            ]
                          }
                        ],
                        "location": {
                          "id": "ga4gh:SL.ovJR3lKrIflg4zDUU3Q-XH715XkwgTJl",
                          "type": "SequenceLocation",
                          "name": null,
                          "aliases": [],
                          "description": "Amino acid position 12 of the Refseq protein NP_004976.2, which is the protein product of the MANE Select coding transcript for KRAS (refseq:NM_004985.5).",
                          "digest": "ovJR3lKrIflg4zDUU3Q-XH715XkwgTJl",
                          "sequenceReference": {
                            "id": "ga4gh:SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS",
                            "type": "SequenceReference",
                            "name": "NP_004976.2",
                            "aliases": [
                              "ensembl:ENSP00000308495.3",
                              "ga4gh:SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS",
                              "refseq:NP_004976.2"
                            ],
                            "description": "The protein product of the MANE Select coding transcript for KRAS (refseq:NM_004985.5), corresponding to the Refseq protein accession NP_004976.2.",
                            "moleculeType": "protein",
                            "refgetAccession": "SQ.fytWhQSNGnA-86vDiQCxTSzgkk_WfQRS",
                            "residueAlphabet": "aa"
                          },
                          "start": 11,
                          "end": 12,
                          "sequence": "G"
                        },
                        "state": {
                          "type": "LiteralSequenceExpression",
                          "sequence": "C"
                        }
                      },
                      "relations": []
                    },
                    {
                      "type": "FeatureContextConstraint",
                      "featureContext": {
                        "id": "gene:hgnc:6407",
                        "conceptType": "Gene",
                        "name": "KRAS",
                        "primaryCoding": {
                          "id": "coding:hgnc:6407",
                          "code": "HGNC:6407",
                          "system": "https://genenames.org",
                          "iris": [
                            "https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:6407"
                          ]
                        },
                        "mappings": [
                          {
                            "relation": "exactMatch",
                            "coding": {
                              "id": "coding:ensembl:ensg00000133703",
                              "code": "ENSG00000133703",
                              "system": "https://www.ensembl.org",
                              "iris": [
                                "https://www.ensembl.org/id/ENSG00000133703"
                              ]
                            }
                          },
                          {
                            "relation": "exactMatch",
                            "coding": {
                              "id": "coding:ncbi:3845",
                              "code": "3845",
                              "system": "https://www.ncbi.nlm.nih.gov/gene",
                              "iris": [
                                "https://www.ncbi.nlm.nih.gov/gene/3845"
                              ]
                            }
                          },
                          {
                            "relation": "relatedMatch",
                            "coding": {
                              "id": "coding:refseq:NM_004985.5",
                              "code": "NM_004985.5",
                              "system": "https://www.ncbi.nlm.nih.gov/nuccore",
                              "iris": [
                                "https://www.ncbi.nlm.nih.gov/nuccore/NM_004985.5"
                              ]
                            }
                          }
                        ]
                      }
                    }
                  ],
                  "extensions": [
                    {
                      "name": "biomarker_type",
                      "value": "Somatic variant"
                    },
                    {
                      "name": "chromosome",
                      "value": "12"
                    },
                    {
                      "name": "start_position",
                      "value": 25398285
                    },
                    {
                      "name": "end_position",
                      "value": 25398285
                    },
                    {
                      "name": "reference_allele",
                      "value": "C"
                    },
                    {
                      "name": "alternate_allele",
                      "value": "A"
                    },
                    {
                      "name": "cdna_change",
                      "value": "c.34G>T"
                    },
                    {
                      "name": "protein_change",
                      "value": "p.G12C"
                    },
                    {
                      "name": "variant_annotation",
                      "value": "Missense"
                    },
                    {
                      "name": "exon",
                      "value": 2
                    },
                    {
                      "name": "rsid",
                      "value": "rs121913530"
                    },
                    {
                      "name": "hgvsg",
                      "value": "12:g.25398285C>A"
                    },
                    {
                      "name": "hgvsc",
                      "value": "ENST00000256078.4:c.34G>T"
                    }
                  ]
                }
              }
            ],
            "description": "The biomarkers associated with this Proposition, each with a `present` flag indicating if the biomarker is present (true) or absent (false). Multiple biomarkers are combined with implied AND logic."
          }
        ]
      },
      "strength": {
        "id": "str:ncit:C25425",
        "conceptType": "Evidence",
        "name": "Approval",
        "mappings": [],
        "primaryCoding": {
          "id": "coding:ncit:C25425",
          "code": "C25425",
          "name": "Approval",
          "system": "https://evsexplore.semantics.cancer.gov",
          "systemVersion": "26.08e",
          "iris": [
            "https://evsexplore.semantics.cancer.gov/evsexplore/concept/ncit/C25425"
          ]
        }
      },
      "extensions": [
        {
          "name": "status",
          "value": "Active",
          "description": "Whether this Statement is Active, Superseded, or Deprecated within moalmanac-db."
        },
        {
          "name": "indication",
          "value": {
            "id": "ind:ema:lumykras:0",
            "type": "Indication",
            "description": "LUMYKRAS as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with KRAS G12C mutation and who have progressed after at least one prior line of systemic therapy.",
            "contributions": [
              {
                "id": "ctrb:vanallenlab:2024-10-20:0",
                "type": "Contribution",
                "description": "Adding EMA approvals for use to database",
                "date": "2024-10-20",
                "contributor": {
                  "id": "agent:user:vanallenlab",
                  "type": "Agent",
                  "agentType": "contributor",
                  "name": "Van Allen lab",
                  "description": "Van Allen lab, Dana-Farber Cancer Institute"
                }
              },
              {
                "id": "ctrb:ema:2022-01-06:0",
                "type": "Contribution",
                "description": "Indication received approval from the European Commission.",
                "date": "2022-01-06",
                "contributor": {
                  "id": "agent:org:ema",
                  "type": "Agent",
                  "agentType": "organization",
                  "name": "European Medicines Agency",
                  "description": "Regulatory agency that approves medicines for use in the European Union."
                }
              }
            ],
            "reportedIn": [
              {
                "id": "doc:ema:lumykras",
                "type": "Document",
                "documentType": "Regulatory approval",
                "name": "Lumykras (sotorasib) [product information]. EMA.",
                "title": null,
                "aliases": [],
                "description": "Amgen Europe BV. Lumykras (sotorasib) [product information]. European Medicines Agency website. https://www.ema.europa.eu/en/documents/product-information/lumykras-epar-product-information_en.pdf. Revised February 2024. Accessed March 19, 2024.",
                "urls": [
                  "https://www.ema.europa.eu/en/documents/product-information/lumykras-epar-product-information_en.pdf",
                  "https://www.ema.europa.eu/en/medicines/human/EPAR/lumykras"
                ],
                "doi": null,
                "pmid": null,
                "extensions": [
                  {
                    "name": "agent",
                    "value": {
                      "id": "agent:org:ema",
                      "type": "Agent",
                      "agentType": "organization",
                      "name": "European Medicines Agency",
                      "description": "Regulatory agency that approves medicines for use in the European Union."
                    },
                    "description": "The organization that published this document."
                  },
                  {
                    "name": "company",
                    "value": "Amgen Europe BV.",
                    "description": "The company that manufactures the cancer drug. Only applicable to market authorization documents."
                  },
                  {
                    "name": "drug_name_brand",
                    "value": "Lumykras",
                    "description": "The brand name of the cancer drug, per this document. Only applicable to market authorization documents."
                  },
                  {
                    "name": "drug_name_generic",
                    "value": "sotorasib",
                    "description": "The generic name of the cancer drug, per this document. Only applicable to market authorization documents."
                  },
                  {
                    "name": "first_publication_date",
                    "value": "2022-03-31",
                    "description": "The publication date for the initial version of this document."
                  },
                  {
                    "name": "identification_number",
                    "value": null,
                    "description": "Identification number used by the publishing organization."
                  },
                  {
                    "name": "publication_date",
                    "value": "2024-02-27",
                    "description": "The publication date for the document."
                  },
                  {
                    "name": "status",
                    "value": "Active",
                    "description": "Whether this document is Active or Deprecated within moalmanac-db."
                  }
                ]
              }
            ],
            "extensions": [
              {
                "name": "status",
                "value": "Approved",
                "description": "Current approval status."
              }
            ]
          },
          "description": "The underlying Indication supporting this Statement."
        }
      ]
    }
  ]
}